Natco Pharma’s Mekaguda API Unit Clears USFDA Inspection With Minor Observation

Unknown Apr 02, 2026 1,050 Views

Natco Pharma Ltd has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its Active Pharmaceutical Ingredients (API) facility located in Mekaguda, Hyderabad. The inspection, conducted between June 9 and June 13, 2025, concluded with a single observ...